BiotechTube
Home/Mustang Bio/Adam J. Chill
AJ

Adam J. Chill

Director

Mustang Bio

Therapeutic Areas

Oncology

Mustang Bio Pipeline

DrugIndicationPhase
MB-101High-Grade Glioma / GlioblastomaPhase 1
MB-106Relapsed/Refractory B-cell NHL & CLLPhase 1/2
MB-108Glioblastoma / Malignant GliomaPhase 1

Leadership Team at Mustang Bio

ML
Manuel Litchman, M.D.
President, Chief Executive Officer and Director
GF
Greg Furrow, M.S., FRQA
Chief Quality Officer
MS
Michael S. Weiss
Chairman of the Board of Directors
LA
Lindsay A. Rosenwald, M.D.
Director
View full Mustang Bio profile